154 related articles for article (PubMed ID: 23615982)
1. Concurrent chemoradiotherapy with low dose weekly gemcitabine in medically inoperable muscle-invasive bladder cancer patients.
Atasoy BM; Dane F; Alsan Cetin I; Ozgen Z; Ucuncu Kefeli A; Ibrahimov R; Turhal NS; Abacioglu U; Turkeri L
Clin Transl Oncol; 2014 Jan; 16(1):91-5. PubMed ID: 23615982
[TBL] [Abstract][Full Text] [Related]
2. Phase II study of conformal hypofractionated radiotherapy with concurrent gemcitabine in muscle-invasive bladder cancer.
Choudhury A; Swindell R; Logue JP; Elliott PA; Livsey JE; Wise M; Symonds P; Wylie JP; Ramani V; Sangar V; Lyons J; Bottomley I; McCaul D; Clarke NW; Kiltie AE; Cowan RA
J Clin Oncol; 2011 Feb; 29(6):733-8. PubMed ID: 21205754
[TBL] [Abstract][Full Text] [Related]
3. An Effective and Well Tolerated Strategy of Bladder Preservation Therapy in Cisplatin-Ineligible Patients With Muscle-Invasive Bladder Cancer.
Feng YH; Shen KH; Huang KH; Tzeng WS; Li CF; Lin KL
Clin Genitourin Cancer; 2016 Feb; 14(1):e67-74. PubMed ID: 26428609
[TBL] [Abstract][Full Text] [Related]
4. Radiotherapy concurrent with weekly gemcitabine after transurethral tumor resection in muscle ınvasive bladder cancer.
Demirci U; Dızdar O; Cetindag MF; Altınova S; Ozsavran A; Dede DS; Kızılırmak N; Eraslan FA; Yalcın B; Cinkir HY
J Cancer Res Ther; 2015; 11(4):704-7. PubMed ID: 26881505
[TBL] [Abstract][Full Text] [Related]
5. Phase I study of conformal radiotherapy with concurrent gemcitabine in locally advanced bladder cancer.
Sangar VK; McBain CA; Lyons J; Ramani VA; Logue JP; Wylie JP; Clarke NW; Cowan RA
Int J Radiat Oncol Biol Phys; 2005 Feb; 61(2):420-5. PubMed ID: 15667962
[TBL] [Abstract][Full Text] [Related]
6. Combined chemoradiotherapy with gemcitabine in patients with locally advanced inoperable transitional cell carcinoma of the urinary bladder and/or in patients ineligible for surgery: a phase I trial.
De Santis M; Bachner M; Cerveny M; Kametriser G; Steininger T; Königsberg R; Schratter-Sehn A; Sedlmayer F; Dittrich C
Ann Oncol; 2014 Sep; 25(9):1789-1794. PubMed ID: 24936582
[TBL] [Abstract][Full Text] [Related]
7. Combined chemoradiation therapy with twice-weekly gemcitabine and cisplatin for organ preservation in muscle-invasive bladder cancer: long-term results of a phase 1 trial.
Azria D; Riou O; Rebillard X; Thezenas S; Thuret R; Fenoglietto P; Pouessel D; Culine S
Int J Radiat Oncol Biol Phys; 2014 Mar; 88(4):853-9. PubMed ID: 24368064
[TBL] [Abstract][Full Text] [Related]
8. Phase I study of radiochemotherapy with gemcitabine in invasive bladder cancer.
Borut K; Lijana ZK
Radiother Oncol; 2012 Mar; 102(3):412-5. PubMed ID: 21890225
[TBL] [Abstract][Full Text] [Related]
9. Combined-modality therapy with gemcitabine and radiation therapy as a bladder preservation strategy: long-term results of a phase I trial.
Oh KS; Soto DE; Smith DC; Montie JE; Lee CT; Sandler HM
Int J Radiat Oncol Biol Phys; 2009 Jun; 74(2):511-7. PubMed ID: 18977098
[TBL] [Abstract][Full Text] [Related]
10. Long-Term Outcomes Among Patients Who Achieve Complete or Near-Complete Responses After the Induction Phase of Bladder-Preserving Combined-Modality Therapy for Muscle-Invasive Bladder Cancer: A Pooled Analysis of NRG Oncology/RTOG 9906 and 0233.
Mitin T; George A; Zietman AL; Heney NM; Kaufman DS; Uzzo RG; Dreicer R; Wallace HJ; Souhami L; Dobelbower MC; Sandler HM; Shipley WU
Int J Radiat Oncol Biol Phys; 2016 Jan; 94(1):67-74. PubMed ID: 26700703
[TBL] [Abstract][Full Text] [Related]
11. Gemcitabine, cisplatin, and hyperfractionated accelerated radiotherapy for locally advanced non-small cell lung cancer.
Zwitter M; Kovac V; Smrdel U; Strojan P
J Thorac Oncol; 2006 Sep; 1(7):662-6. PubMed ID: 17409933
[TBL] [Abstract][Full Text] [Related]
12. Concurrent gemcitabine and radiotherapy for the treatment of muscle-invasive bladder cancer: A pooled individual data analysis of eight phase I-II trials.
Caffo O; Thompson C; De Santis M; Kragelj B; Hamstra DA; Azria D; Fellin G; Pappagallo GL; Galligioni E; Choudhury A
Radiother Oncol; 2016 Nov; 121(2):193-198. PubMed ID: 27720221
[TBL] [Abstract][Full Text] [Related]
13. Neoadjuvant Dose Dense MVAC versus Gemcitabine and Cisplatin in Patients with cT3-4aN0M0 Bladder Cancer Treated with Radical Cystectomy.
Zargar H; Shah JB; van Rhijn BW; Daneshmand S; Bivalacqua TJ; Spiess PE; Black PC; Kassouf W;
J Urol; 2018 Jun; 199(6):1452-1458. PubMed ID: 29329894
[TBL] [Abstract][Full Text] [Related]
14. Gemcitabine based trimodality treatment in patients with muscle invasive bladder cancer: May neutrophil lymphocyte and platelet lymphocyte ratios predict outcomes?
Hurmuz P; Ozyigit G; Kilickap S; Esen CSB; Akdogan B; Ozen H; Akyol F
Urol Oncol; 2021 Jun; 39(6):368.e19-368.e29. PubMed ID: 33189528
[TBL] [Abstract][Full Text] [Related]
15. Radiochemotherapy with Gemcitabine in Unresectable Extrahepatic Cholangiocarcinoma: Long-term Results of a Phase II Study.
Autorino R; Mattiucci GC; Ardito F; Balducci M; Deodato F; Macchia G; Mantini G; Perri V; Tringali A; Gambacorta MA; Tagliaferri L; Giuliante F; Morganti AG; Valentini V
Anticancer Res; 2016 Feb; 36(2):737-40. PubMed ID: 26851032
[TBL] [Abstract][Full Text] [Related]
16. A pilot study of concurrent chemoradiotherapy with gemcitabine and cisplatin in patients with locally advanced biliary tract cancer.
Lee KJ; Yi SW; Cha J; Seong J; Bang S; Song SY; Kim HM; Park SW
Cancer Chemother Pharmacol; 2016 Oct; 78(4):841-6. PubMed ID: 27586966
[TBL] [Abstract][Full Text] [Related]
17. Neoadjuvant chemotherapy with gemcitabine and cisplatin followed by selective bladder preservation chemoradiotherapy in muscle-invasive urothelial carcinoma of bladder.
Sung HH; Kim H; Kim R; Kim CK; Kwon GY; Park W; Song W; Jeong BC; Park SH
Investig Clin Urol; 2022 Mar; 63(2):168-174. PubMed ID: 35244990
[TBL] [Abstract][Full Text] [Related]
18. Combined-modality therapy with gemcitabine and radiotherapy as a bladder preservation strategy: results of a phase I trial.
Kent E; Sandler H; Montie J; Lee C; Herman J; Esper P; Fardig J; Smith DC
J Clin Oncol; 2004 Jul; 22(13):2540-5. PubMed ID: 15226322
[TBL] [Abstract][Full Text] [Related]
19. The impact of intravesical gemcitabine and 1/3 dose Bacillus Calmette-Guérin instillation therapy on the quality of life in patients with nonmuscle invasive bladder cancer: results of a prospective, randomized, phase II trial.
Gontero P; Oderda M; Mehnert A; Gurioli A; Marson F; Lucca I; Rink M; Schmid M; Kluth LA; Pappagallo G; Sogni F; Sanguedolce F; Schiavina R; Martorana G; Shariat SF; Chun F
J Urol; 2013 Sep; 190(3):857-62. PubMed ID: 23545101
[TBL] [Abstract][Full Text] [Related]
20. Tolerability of Concurrent Chemoradiation Therapy With Gemcitabine (GemX), With and Without Prior Neoadjuvant Chemotherapy, in Muscle Invasive Bladder Cancer.
Thompson C; Joseph N; Sanderson B; Logue J; Wylie J; Elliott T; Lyons J; Anandadas C; Choudhury A
Int J Radiat Oncol Biol Phys; 2017 Mar; 97(4):732-739. PubMed ID: 28244408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
